Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Novo Nordisk Pharmaceutical Industries LP
FDA Inspection
•Novo Nordisk Pharmaceutical Industries LP•August 29, 2024

Novo Nordisk Pharmaceutical Industries LP – FDA Inspection, Aug 29, 2024

Record Details

This FDA Inspection record concerns Novo Nordisk Pharmaceutical Industries LP, with an inspection on August 29, 2024, issued by the Atlanta District Office, covering human drugs.

Company
Novo Nordisk Pharmaceutical Industries LP
Inspection Date
August 29, 2024
Product Type
Human Drugs
Office
Atlanta District Office
People
  • Chunsheng Cai (Company Rep)
  • James Norman (Issuing Officer)
  • Marian E. Ramirez (Company Rep)
  • Sarah C Zimmermann (Issuing Officer)
  • Simone E. Pitts (FDA Associated Person)
View Company Profile

ID · 0d4e4024-802a-47e4-ab43-ecd4282325ae

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1248200
FDA center
Human Drugs
Project area
New Drug Evaluation
Outcome
Form 483 issued

FDA Citations

6
  1. 21 CFR 211.100(b)SOPs not followed / documented
  2. 21 CFR 211.111Establishment of time limitations
  3. 21 CFR 211.142(b)Storage under appropriate conditions
  4. 21 CFR 211.166(a)Lack of written stability program
  5. 21 CFR 211.22(a)Approve or reject components, products
  6. 21 CFR 211.46(b)Equipment for Environmental Control

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Novo Nordisk Pharmaceutical Industries LP

4
DateClassificationOfficeProject area
July 30, 2025Not classifiedAtlanta District Office
December 20, 2023NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
December 20, 2018NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
December 1, 2016NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
Other documents for Novo Nordisk Pharmaceutical Industries LP
  • FDA Inspection 1274952 - 2025-07-30
  • FDA Inspection 1233201 - 2023-12-20
  • FDA Inspection 1079946 - 2018-12-20
  • FDA Inspection 1010958 - 2016-12-01

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Novo Nordisk Pharmaceutical Industries LP
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.